Howard, III, Thomas

Howard, III, Thomas was paid $282K by Medicaid between Jan 2020 and Sep 2020, across 9 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 34% of everything it billed.

33Billing provider infoHOWARD, III, THOMAS
LEXINGTON, KY 40508

33aNPI1457580003assigned 07/03/2009

33bProvider typeAddiction Medicine (Internal Medicine) Physician

28Total paid$282K

24GClaims6,883

24DCodes billed9

24AFirst – last monthJan 2020 – Sep 2020

Compared with peers

Next to other Addiction Medicine (Internal Medicine) Physician providers in Kentucky

Rank by total paid#8 of 13

Median peer was paid$671K

This provider vs. median0.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	6,883	$282K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	34%	1,612	807	$95K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	26%	1,535	790	$73K
90837	Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient	15%	539	445	$41K
90853	Group psychotherapy (other than of a multiple-family group)	10%	1,866	1,241	$28K
H0038	Self-help/peer services, per 15 minutes	6.6%	705	464	$19K
90832	Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient	4.6%	353	309	$13K
90834	Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient	2.6%	140	132	$7K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	1.5%	37	28	$4K
81025		<1%	96	91	$792.12

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.